Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria L Bae-Jump

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Journal of Cancer Research and Clinical Oncology|August 28, 2024
Sulindac exhibits anti-proliferative and anti-invasive effects in uterine serous carcinoma cellsShuning Chen, Weimin Kong, Xiaochang Shen, et al.
Cancers|April 14, 2026
Eicosapentaenoic Acid Suppresses Tumor Growth and Enhances Chemosensitivity via AKT/mTOR Signaling in Uterine Serous CarcinomaHaomeng Zhang, Weimin Kong, Xiaochang Shen, et al.
American Journal of Translational Research|April 12, 2018
Novasoy and genistein inhibit endometrial cancer cell proliferation through disruption of the AKT/mTOR and MAPK signaling pathwaysKim M Malloy, Jiandong Wang, Leslie H Clark, et al.
Gynecologic Oncology Reports|March 18, 2021
Genomic profiling of endometrial cancer and relationship with volume of endometrial cancer disease spreadStephanie A Sullivan, Gabriel Hawkins, Xiobai Zhao, et al.
Gynecologic Oncology|June 1, 2014
Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancerMonica N Schointuch, Timothy P Gilliam, Jessica E Stine, et al.
Reproductive Biology and Endocrinology : RB&E|May 11, 2023
PIK3CA mutation in endometriotic epithelial cells promotes viperin-dependent inflammatory response to insulinMike R Wilson, Shannon Harkins, Jake J Reske, et al.
Oncotarget|March 13, 2015
JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancerHaifeng Qiu, Amanda L Jackson, Joshua E Kilgore, et al.
Gynecologic Oncology|January 24, 2024
A personalized probabilistic approach to ovarian cancer diagnosticsDongjo Ban, Stephen N Housley, Lilya V Matyunina, et al.
NPJ Precision Oncology|May 26, 2026
A novel ex vivo platform for functional evaluation of treatment responses in metastatic ovarian cancerAlain Valdivia, Adebimpe Adefolaju, Morrent Thang, et al.
Oncotarget|April 14, 2016
The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancerAnuj Suri, Xiugui Sheng, Kevin M Schuler, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Journal of Cancer Research and Clinical Oncology|August 28, 2024
Sulindac exhibits anti-proliferative and anti-invasive effects in uterine serous carcinoma cellsShuning Chen, Weimin Kong, Xiaochang Shen, et al.
Cancers|April 14, 2026
Eicosapentaenoic Acid Suppresses Tumor Growth and Enhances Chemosensitivity via AKT/mTOR Signaling in Uterine Serous CarcinomaHaomeng Zhang, Weimin Kong, Xiaochang Shen, et al.
American Journal of Translational Research|April 12, 2018
Novasoy and genistein inhibit endometrial cancer cell proliferation through disruption of the AKT/mTOR and MAPK signaling pathwaysKim M Malloy, Jiandong Wang, Leslie H Clark, et al.
Gynecologic Oncology Reports|March 18, 2021
Genomic profiling of endometrial cancer and relationship with volume of endometrial cancer disease spreadStephanie A Sullivan, Gabriel Hawkins, Xiobai Zhao, et al.
Gynecologic Oncology|June 1, 2014
Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancerMonica N Schointuch, Timothy P Gilliam, Jessica E Stine, et al.
Reproductive Biology and Endocrinology : RB&E|May 11, 2023
PIK3CA mutation in endometriotic epithelial cells promotes viperin-dependent inflammatory response to insulinMike R Wilson, Shannon Harkins, Jake J Reske, et al.
Oncotarget|March 13, 2015
JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancerHaifeng Qiu, Amanda L Jackson, Joshua E Kilgore, et al.
Gynecologic Oncology|January 24, 2024
A personalized probabilistic approach to ovarian cancer diagnosticsDongjo Ban, Stephen N Housley, Lilya V Matyunina, et al.
NPJ Precision Oncology|May 26, 2026
A novel ex vivo platform for functional evaluation of treatment responses in metastatic ovarian cancerAlain Valdivia, Adebimpe Adefolaju, Morrent Thang, et al.
Oncotarget|April 14, 2016
The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancerAnuj Suri, Xiugui Sheng, Kevin M Schuler, et al.
Pageof 10